A once promising surgical robotics deal with Auris Health has ended in $1 billion in damages for Johnson & Johnson, with a Delaware judge ruling that the healthcare titan failed to honor its end of a bargain involving two of Auris’ novel surgical robot systems, Monarch and iPlatform.
Source: Drug Industry Daily